Hideki Nakakuma Selected Research

Hideki Nakakuma Research Topics

Disease

10	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020 - 01/2002
8	Neoplasms (Cancer) 09/2018 - 01/2008
5	Hemolysis 06/2018 - 07/2007
2	Cytopenia 01/2020 - 03/2009
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 09/2015
2	Infections 01/2015 - 10/2013
2	Thrombosis (Thrombus) 10/2013 - 07/2007
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2009 - 10/2008
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Bone Marrow Failure Disorders 01/2020
1	Sezary Syndrome (Sezary Erythroderma) 09/2018
1	Disease Progression 09/2018
1	Lymphoma (Lymphomas) 09/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2016
1	Ascites 05/2016
1	Atrophy 05/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2015
1	Heavy Chain Disease 01/2014
1	Thromboembolism 10/2013
1	Leukemia 01/2013
1	Dyspnea (Shortness of Breath) 01/2011
1	Anemia 01/2011
1	Fatigue 01/2011
1	Chronic Renal Insufficiency 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 11/2010
1	Genetic Translocation (Chromosomal Translocation) 09/2009
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2009
1	Viremia 03/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2009
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2009
1	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2009
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2008
1	Wilms Tumor (Wilm's Tumor) 07/2007

Drug/Important Bio-Agent (IBA)

6	eculizumab FDA Link 06/2018 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2007
3	Complement System Proteins (Complement)IBA 10/2013 - 07/2007
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2013 - 10/2008
2	EnzymesIBA 01/2020 - 05/2016
2	LigandsIBA 01/2020 - 11/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2016 - 03/2009
2	Hemoglobins (Hemoglobin)IBA 11/2016 - 01/2011
2	Monoclonal AntibodiesIBA 10/2013 - 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2016
1	BilirubinIBA 05/2016
1	CytokinesIBA 09/2015
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2015
1	Immunoglobulin A (IgA)IBA 01/2014
1	NucleotidesIBA 01/2013
1	CCAAT-Enhancer-Binding ProteinsIBA 09/2012
1	Complement C9 (Complement Component 9)IBA 04/2012
1	Complement Inactivating AgentsIBA 01/2011
1	CaspasesIBA 11/2010
1	NK Cell Lectin-Like Receptor Subfamily KIBA 11/2010
1	CD5 AntigensIBA 09/2009
1	Cyclin D3IBA 09/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2009
1	Rituximab (Mabthera)FDA Link 04/2009
1	SteroidsIBA 03/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2009
1	liposomal doxorubicin (Doxil)FDA Link 03/2009
1	Aurora KinasesIBA 10/2008
1	Methotrexate (Mexate)FDA LinkGeneric 01/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2007
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2007
1	GPI-Linked ProteinsIBA 07/2007
1	WT1 ProteinsIBA 07/2007
1	HypoxanthineIBA 01/2002
1	GuanineIBA 01/2002
1	TransferasesIBA 01/2002

Therapy/Procedure

2	Therapeutics 09/2015 - 03/2009
1	Homologous Transplantation 09/2018
1	Hematopoietic Stem Cell Transplantation 05/2016
1	Drug Therapy (Chemotherapy) 01/2015
1	Erythrocyte Transfusion 10/2013
1	Drug Tapering 03/2009